SMRT GRANT PROGRAM

2022 CANCER TRANSCRIPTOMICS 

Submission deadline: Closed

What is your RNA-seq data missing?

Cancers display widespread RNA dysregulation, including alternative splicing of transcripts. Recent studies clearly show that short-read approaches capture only a fraction of isoforms identified by PacBio’s long-read approach in cancer samples.

If your research could benefit from highly accurate long-read RNA sequencing, apply for this SMRT Grant.


Three winners will receive free sequencing of up to six bulk or single-cell RNA samples.

Get in touch – We are here if you have questions about this SMRT Grant or the official rules.

Submit your proposal below:

By registering on this web page, you are consenting and agreeing to collection and use of that information by PacBio in accordance with its privacy policy.